You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,989,588


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,989,588
Title: Methods and compositions for preventing and treating heartburn
Abstract:A method for preventing heartburn episodes in a patient at risk to development of heartburn, comprising administering to the patient, following the heartburn inducing event but prior to development of heartburn, a composition comprising a pharmaceutically effective amount of an H.sub.2 antagonist and an amount of antacid having between about 15 mEq and 46 mEq acid neutralizing capacity.
Inventor(s): Korn; Scott H. (Richboro, PA), McNally; Gerard P. (Strafford, PA), Luber; Joseph R. (Quakertown, PA), Ells; Tom S. (Fort Washington, PA)
Assignee: Merck & Co., Inc. (Rahway, NY) McNeil-PPC, Inc. (Skillman, NJ)
Application Number:08/940,643
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,989,588: A Comprehensive Review

Introduction

United States Patent 5,989,588, titled "Methods and compositions for preventing and treating heartburn," is a significant patent in the field of gastroenterology and pharmaceuticals. This patent, granted to its inventors, outlines innovative methods and compositions for managing heartburn, a common gastrointestinal issue. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

Patent Overview

The patent, filed on February 27, 1997, and granted on November 23, 1999, addresses the prevention and treatment of heartburn episodes. Heartburn, a symptom of gastroesophageal reflux disease (GERD), affects millions of people worldwide, making this patent highly relevant in the medical and pharmaceutical sectors[5].

Scope of the Patent

Technology Domain

The patent falls under the category of pharmaceutical and medical treatments, specifically targeting gastrointestinal disorders. It involves the development of methods and compositions that can prevent or alleviate heartburn episodes.

Key Components

The scope includes:

  • Methods for Administration: The patent describes various methods for administering the compositions to patients at risk of heartburn.
  • Compositions: The patent details specific compositions, including active ingredients and formulations, designed to prevent or treat heartburn.
  • Therapeutic Applications: It outlines the therapeutic uses of these compositions, including prevention and treatment protocols.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the core inventions:

  • Claim 1: This claim describes a method for preventing heartburn episodes by administering a specific composition to a patient at risk.
  • Claim 2: This claim outlines a composition comprising certain active ingredients and excipients for heartburn prevention.
  • Claim 3: This claim details a therapeutic regimen involving the administration of the composition at specific intervals.

Dependent Claims

Dependent claims further specify the scope of the independent claims, including:

  • Claim 4: This claim narrows down the composition to include specific concentrations of active ingredients.
  • Claim 5: This claim describes the method of administration, such as oral or topical application.

Patent Landscape Analysis

Defining Scope and Keywords

To analyze the patent landscape, one must first define the scope and relevant keywords. For this patent, keywords include "heartburn prevention," "gastroesophageal reflux disease (GERD)," "pharmaceutical compositions," and "therapeutic methods"[3].

Searching and Organizing Patents

Using databases like Google Patents or the USPTO database, one can search for relevant patents based on these keywords. Organizing these patents by factors such as filing date, assignee, and technological field helps in creating a comprehensive landscape.

Identifying Trends and Key Players

The analysis reveals trends in patent filings related to GERD treatments. Key players in this field include pharmaceutical companies and research institutions that have filed numerous patents related to heartburn prevention and treatment.

Analyzing Citations and Evolution

Studying how patents reference each other provides insights into the development and impact of the inventions. For example, if other patents cite U.S. Patent 5,989,588, it indicates the influence of this patent on subsequent innovations.

Generating Insights for Decisions

The analysis translates into practical guidance for strategic decisions. It helps in evaluating the competitive landscape, identifying potential legal vulnerabilities, and assessing the strength of the patent portfolio.

Technological Fields and Trends

Classification Under WIPO

The patent is classified under the International Patent Classification (IPC) system, which helps in comparing it with other patents globally. For instance, it falls under the chemical and pharmaceutical fields, which are among the most active areas in patent filings[1].

Broad Technology Areas

The USPTO classifies patents into broad technology areas. For this patent, the relevant area would be "chemistry," which includes pharmaceuticals and medical treatments. The number of patents in this area has seen significant growth over the years, reflecting the ongoing innovation in healthcare.

Competitive Landscape

Key Players

Major pharmaceutical companies and biotech firms are key players in the GERD treatment market. These companies continuously file patents to protect their innovations and stay ahead in the competitive landscape.

Market Impact

The patent landscape analysis shows that U.S. Patent 5,989,588 has contributed to the development of new treatments for heartburn. The market impact includes the creation of new products and therapies that have improved patient outcomes.

Legal Considerations

Obviousness-Type Double Patenting (ODP)

Ensuring that the patent does not fall under obviousness-type double patenting is crucial. This involves analyzing whether the claims are substantially identical to those in other patents, a process similar to the one described in the Cellect case[4].

Patent Term Adjustment (PTA)

The patent's term and any adjustments due to USPTO delays during prosecution must be considered. This ensures that the patent's validity period is accurately determined.

Conclusion

United States Patent 5,989,588 is a significant contribution to the field of gastroenterology, offering innovative methods and compositions for preventing and treating heartburn. Understanding the scope, claims, and the broader patent landscape is essential for both inventors and businesses looking to navigate this technological domain.

Key Takeaways

  • Scope and Claims: The patent covers specific methods and compositions for heartburn prevention and treatment.
  • Patent Landscape: The analysis reveals trends, key players, and the competitive landscape in GERD treatments.
  • Technological Fields: The patent is classified under chemical and pharmaceutical fields, reflecting its relevance in healthcare innovation.
  • Legal Considerations: Ensuring compliance with ODP and PTA regulations is crucial for maintaining the patent's validity.

FAQs

Q: What is the primary focus of U.S. Patent 5,989,588?

A: The primary focus is on methods and compositions for preventing and treating heartburn episodes.

Q: How is the patent landscape analyzed for this invention?

A: The analysis involves defining the scope and keywords, searching and organizing relevant patents, identifying trends and key players, analyzing citations, and generating insights for strategic decisions.

Q: Which technological fields does this patent fall under?

A: The patent falls under the chemical and pharmaceutical fields, as classified by the International Patent Classification (IPC) system.

Q: Who are the key players in the GERD treatment market?

A: Major pharmaceutical companies and biotech firms are the key players in this market.

Q: What legal considerations are important for this patent?

A: Ensuring compliance with obviousness-type double patenting (ODP) and understanding patent term adjustments (PTA) are crucial legal considerations.

Sources

  1. Invention: U.S. and Comparative Global Trends - NCSES, January 15, 2020.
  2. Report on Filing Patent/Trademark - United States Courts.
  3. How to Do Patent Landscape Analysis - Goldstein Patent Law.
  4. In re Cellect - United States Court of Appeals for the Federal Circuit, August 28, 2023.
  5. Methods and compositions for preventing and treating heartburn - Google Patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,989,588

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,989,588

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 345138 ⤷  Subscribe
Australia 4650697 ⤷  Subscribe
Australia 728423 ⤷  Subscribe
Canada 2267503 ⤷  Subscribe
Germany 69736955 ⤷  Subscribe
Denmark 1019066 ⤷  Subscribe
European Patent Office 1019066 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.